Cargando…
OAO5-04. Gp96-Ig-SIV vaccines induce predominant immune responses at mucosal sites
Autores principales: | Strbo, N, Vaccari, M, Pahwa, S, Kolber, MA, Fisher, E, Gonzalez, L, Felber, BK, Pavlakis, GN, Franchini, G, Podack, ER |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767556/ http://dx.doi.org/10.1186/1742-4690-6-S3-O34 |
Ejemplares similares
-
P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination
por: Gonzalez, LE, et al.
Publicado: (2009) -
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
por: Valentin, A, et al.
Publicado: (2009) -
Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
por: Fisher, Eva, et al.
Publicado: (2021) -
P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors
por: Felber, BK, et al.
Publicado: (2009) -
Secreted heat shock protein gp96-Ig and OX40L-Fc combination vaccine enhances SARS-CoV-2 Spike (S) protein-specific B and T cell immune responses
por: Padula, Laura, et al.
Publicado: (2022)